TROPION-Lung12: A phase 3 study of adjuvant datopotamab deruxtecan and rilvegostomig in ctDNA-positive or high-risk pathology stage I non-small cell lung cancer
TROPION-Lung12:一项针对ctDNA阳性或高危病理I期非小细胞肺癌的辅助治疗的3期研究
期刊:Journal of Thoracic and Cardiovascular Surgery
影响因子:4.4
doi:10.1016/j.jtcvs.2025.09.017
Jones, David R; Opitz, Isabelle; Harpole, David; Yanagawa, Jane; Lim, Eric; Tsutani, Yasuhiro; Tan, Daniel S W; Dacic, Sanja; Ganti, Apar Kishor; Bodla, Shankar; Batig, Anastasiya; Lyfar, Pavlo; Forcina, Alessandra; Felip, Enriqueta